Loading page…
Kaken Pharmaceutical Co Ltd 2025 Annual Report with Sustainability Disclosures
Company: Kaken Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 54
The report presents FY2024 consolidated net sales of ¥94,035 million and operating profit of ¥21,034 million. It reports Scope 1 and 2 emissions of 20,136 t-CO2 and waste generated of 1,169.5 t. KAKEN revised its material issues and describes Board oversight of sustainability progress through its Sustainability Committee.
Indicators available in this report: